Share this video  

SABCS 2020 | Upcoming advances in breast cancer

Wolfgang Janni, MD, PhD, Ulm University, Ulm, Germany, discusses the upcoming advances in triple-negative breast cancer (TNBC) including immunotherapy for triple-negative breast cancer as well as new targeted agents for HER2-positive breast cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).